ArticleHuman vaccines & immunotherapeutics2022
Bibliometric analysis of the 100 top-cited articles on immunotherapy of urological cancer.
Article in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.
- A 23-year bibliometric analysis of the development of global research on hereditary renal carcinoma.Frontiers in oncology · 2024Pooled it
- Dyslexia: A Bibliometric and Visualization Analysis.Frontiers in public health · 2022Pooled it
- A bibliometric analysis of artificial intelligence in ovarian cancer research from 2006 to 2025.Discover oncology · 2026Article
- A bibliometric study of the top 100 most-cited papers in ureteral stricture reconstruction.Translational andrology and urology · 2025Article
- Global research trends and hotspots on imaging of bladder cancer: A bibliometric and visual analysis from 1981 to 2023.Medicine · 2025Article
- Sustainability of new energy vehicles from a battery recycling perspective: A bibliometric analysis.Heliyon · 2024Review
- Bibliometric insights into drug resistance in bladder cancer: Two decades of progress (1999-2022).Heliyon · 2024Article
- Systematic bibliometric analysis of research hotspots and trends on the application of premium IOLs in the past 2 decades.International journal of ophthalmology · 2024Article
- Bibliometric mapping of the landscape and structure of nutrition and depression research: visualization analysis.Journal of health, population, and nutrition · 2023Article
- Research of targeted therapy for renal cancer from 2006 to 2022: a bibliometric and visualized analysis.Translational andrology and urology · 2023Article
- Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma.Frontiers in oncology · 2023Article
- Advances in artificial muscles: A brief literature and patent review.Frontiers in bioengineering and biotechnology · 2023Review
- Rising focus on neuropsychiatric risks: A half-century bibliometric analysis of sevoflurane literature.Saudi journal of anaesthesiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo highlight the scientific progress in immunotherapy of urological cancer by identifying and analyzing the 100 top-cited (T100) articles from the last 15 years.
methodsPapers in immunotherapy of urological cancer were identified from Clarivate Web of Science Core Collection database. Data of the T100 articles and papers published in recent 2 years, including citations, topic, year of publication, country of origin, institution and authorship, were extracted and analyzed.
resultsOf the T100 articles, the citation number ranged from 7387 to 183 with a mean of 590.66. The USA led the field with 80 T100 articles and 53097 citations. Pro Sharma P from MD Anderson Cancer Center was at the top of list with 8 T100 articles (3 as first author and 6 as corresponding author). Memorial Sloan Kettering Cancer Center ranked first with 26 T100 articles and 22573 citations, followed by Johns Hopkins University with 21 T100 articles and 25095 citations. Forty-nine T100 articles were related to the renal cancer, followed by prostate cancer (29), bladder cancer (13) and urothelial cancer (13). According to the type of immunotherapy, most T100 articles were related to ICI (55 articles) and vaccine (19 articles).
conclusionsIt is the first bibliometric analysis to identify the T100 articles on immunotherapy of urological cancer. The USA made great contribution in the field of immunotherapy related to urological cancer. Renal, bladder and prostate cancers were the major organs treated by immunotherapy especially by ICIs and vaccines. The multiple aspects of ICIs research in renal and bladder cancer and the neoantigen-based vaccine therapy will be hotspots for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.